Stockreport

Citizens Highlights BeOne Medicines' (ONC) $3.8B Revenue Potential for 2025 [Yahoo! Finance]

BeOne Medicines Ltd. - American Depositary Shares  (ONC) 
PDF rating and $396 price target for BeOne Medicines Ltd. (NASDAQ:ONC), citing strong effectiveness results from a Phase 3 trial in gastric cancer patients. BeOne Medicines [Read more]